Cyclo Therapeutics, Inc. 8-K Report: Stock Insights & Updates (March 2023)

Here are the key insights extracted from the provided financial report section:
- Entity Information:
- Company Name: Cyclo Therapeutics, Inc.
- CIK Number: 0000922247
- SEC File Number: 000-25466
- IRS Employer Identification Number (EIN): 59-3029743
- Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
- Phone Number: 386-418-8060
- Stock Information:
- Common Stock: The par value of the common stock is $0.0001 per share.
- Ticker Symbol: CYTH (Common Stock), CYTHW (Warrants to Purchase Common Stock)
- Exchange: NASDAQ
- Reporting Period:
- Report Date: March 20, 2023
- The report covers a single day (March 20, 2023).
- Stock Categories and Custom Members:
- The report includes classifications for different stock types:
- Common Stock Par Value: $0.0001 per share.
- Warrants to Purchase Common Stock.
- XML and XBRL Context:
- The report utilizes XML and XBRL (eXtensible Business Reporting Language) for structuring financial information.
- Relevant namespaces include US GAAP and custom dimensions for stock classification.
- Document Type:
- This filing appears to be an 8-K form, which is used for reporting unscheduled material events or corporate changes.
Summary:
Cyclo Therapeutics, Inc. reported on March 20, 2023, concerning its common stock and warrants. The common stock has a par value of $0.0001 and is traded under the ticker symbol CYTH on NASDAQ, while warrants are under CYTHW. The report is structured using XBRL for better data management and reporting compliance.